USA TODAY Sports

Bank shots: NBA betting news and notes

Each week, we look back on the NBA betting scene and give you the best –and worst – basketball bets, as well as some spots to keep an eye on with the upcoming schedule.

For the week of March 17-24.

Hottest ATS

New York Knicks (4-1 SU, 5-0 ATS)

The Knicks have been ravaged with injuries but still reeled off five consecutive covers this past week. New York was a rare underdog three times during the streak and clinched a playoff berth in the process. The Knicks visit the Boston Celtics Tuesday before enjoying a three-game homestand at Madison Square Garden.

Coldest ATS

Toronto Raptors (0-4 SU, 0-4 ATS)

The Raptors fell twice to the Knicks and also blew covers against the Heat and Bobcats last week. To make matters worse, Rudy Gay left Friday’s loss to New York with a back problem. He will have some time to heal before Atlanta rolls into the Air Canada Centre on Wednesday.

Best over play

Brooklyn Nets (2-2 SU, 4-0 over/under)

The Nets have played over the number in seven straight games. Brooklyn has been putting up big numbers (104 ppg) during the over streak and has four games remaining on its current eight-game road trip. The Nets get a few days off before visiting Portland on Wednesday.

Best under play

Houston Rockets (3-1 SU, 0-4 over/under)

The Rockets have gone low in six straight games and eight of their last nine. Houston averages a league-best 106.4 points per game but its defense has stepped up and held opponents to an average of 92.5 points during the under run – more than 10 points lower than its season average (102.8). The Rockets host the Pacers on Wednesday.

All stats prior to action Monday.

If you have any feedback or suggestions for our Editorial Team, please contact us at Editorial

            share   SHARE   rss   RSS FEED   email   EMAIL   print   PRINT

There haven't been any comments posted on this article. Be the first to respond!

You are currently not logged in.
Login | Signup | Help
You must be logged in to post a comment.

Top Response

There have been no comments on this article. Be the first to respond!